Key Points:
- Oura plans to raise approximately $2.1 billion through an IPO of 50 million shares priced at $40 to $44, with 73% of the offering consisting of secondary shares.
- At the midpoint, Oura would command a fully diluted market value of approximately $14.9 billion, making it one of the largest consumer technology IPOs in the current US pipeline.
- The company had 5.0 million paid members across 56 markets as of June 30, 2026, while recurring subscriptions represented 20% of revenue during the first nine months of fiscal 2026.
Oura, the smart ring maker that combines wearable hardware with subscription-based health insights, has set terms for a highly anticipated US IPO that could raise approximately $2.1 billion. The San Francisco-based company plans to offer 50 million shares at $40 to $44, with the deal expected to price during the week of September 28, 2026. At the midpoint, Oura would command a fully diluted market value of approximately $14.9 billion, putting the consumer technology company among the largest IPOs in the current pipeline.
Company Background: Wearable Hardware Meets Recurring Health Revenue
Founded in 2013, Oura operates an integrated wearable technology and digital health platform built around its finger-worn sensor ring. The device tracks sleep, activity, stress, heart health and women’s health, while its companion application converts the collected information into more than 50 metrics and AI-generated guidance. The model combines hardware sales with recurring membership subscriptions that unlock the broader health-insight platform.
Hardware accounted for approximately 80% of revenue during the first nine months of fiscal 2026, while membership subscriptions contributed the remaining 20%. Oura sells directly to consumers and through approximately 8,400 retail locations, while also reaching customers through employers, government organizations and healthcare partners. As of June 30, 2026, the company had 5.0 million paid members across 56 markets, representing a 100% year-over-year increase, with approximately 85% 12-month paid-member retention. Oura generated approximately $1.4 billion in revenue for the 12 months ended June 30, 2026.
IPO Details: $2.1 Billion Offering Targets $14.9 Billion Valuation
Oura plans to offer 50 million shares at $40 to $44, targeting approximately $2.1 billion in gross proceeds. About 73% of the offering is secondary, meaning the majority of shares are being sold by existing shareholders rather than issued by the company. At the midpoint of the proposed range, the fully diluted market value would reach approximately $14.9 billion.
The company plans to list on the Nasdaq under the ticker OURA. Cornerstone investors Eli Lilly and Dragoneer Investment Group have indicated interest in approximately $400 million of the IPO, representing about 19% of the transaction. Goldman Sachs, Morgan Stanley, J.P. Morgan, Allen & Company, Jefferies, BofA Securities, Barclays, Wells Fargo Securities, Citizens JMP, KeyBanc Capital Markets, Guggenheim Securities, Canaccord Genuity, Needham & Co., Raymond James, Rothschild, Truist Securities and William Blair are serving as joint bookrunners.
Market Context and Growth Opportunities
Oura’s IPO arrives as the US stock market’s technology pipeline broadens beyond artificial intelligence infrastructure. Renaissance Capital identified Oura as a rare high-growth consumer technology IPO when the company filed in September, alongside larger technology and infrastructure offerings entering the fall market. The Renaissance IPO Index was up 17.6% year to date as of September 3, compared with a 14.0% gain for the S&P 500, indicating a supportive backdrop for newly public companies, although individual IPO performance can vary considerably.
The company’s combination of hardware and recurring membership revenue provides a potentially differentiated model within the wearable technology market. Its rapidly expanding paid-member base also gives Oura a larger installed base from which to develop subscription revenue and additional health-related services. However, the proposed $14.9 billion valuation places significant attention on whether continued member growth and subscription expansion can support the expectations embedded in the IPO price.
Risks and Challenges
Oura faces competition across wearable technology, smart rings, fitness tracking and digital health, including companies with significantly larger consumer ecosystems. Its business also depends on continued product innovation, accurate sensor performance, subscription retention and the ability to translate biometric data into services that customers continue to value. Regulatory considerations surrounding health-related data and privacy could also become increasingly important as the platform expands its health capabilities.
The proposed $2.1 billion IPO gives Oura a substantial public-market profile and introduces one of the more prominent consumer technology listings to the September 2026 IPO calendar. The combination of 5.0 million paid members, $1.4 billion in trailing revenue and strong subscription growth provides investors with an established operating base rather than a purely early-stage technology story. The key market question will be whether Oura can sustain that growth at a valuation approaching $15 billion once OURA begins trading on the Nasdaq.
